GRAIL 2026 Analyst Call | Q1 Galleri Test Screening Volume Jumps 50% To Drive $40.8M Revenue Beat Investing 101 7 hours ago Play Download
GRAL: Can This Cancer Test Stock Deliver? ($GRAL Analysis) StockAnalyticsAI 6 months ago Play Download
Grail expected to be first FDA-approved multi-cancer test, says CEO Bob Ragusa CNBC Television 1 year ago Play Download
GRAIL Stock CRASHED 50%... Why This is the Ultimate Buying Opportunity! 🚨 GRAL STOCK PODCAST TODAY ​The Opening Bell Report 3 months ago Play Download
Our Rotation Call Paid Off: Now What? (IGV Risk Management Update) 7th Key Financial 6 hours ago Play Download
